In addition, both compounds were shown to potently suppress tumor growth and the AKT pathway in xenograft models harboring either WT or AKT1-E17K, with ARQ 751 consistently demonstrating superior potency compared to ARQ 092. Here, AKT1 is linked to neoplasm.